[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Anna Arthur, PhD\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":57},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":26,"conditions":27,"keywords":29,"overallStatus":45,"whyStopped":4,"lastUpdateSubmitDate":46,"lastUpdatePostDateStruct":47,"startDateStruct":50,"completionDateStruct":52,"leadSponsor":54,"locationsCount":4},"100606824","phase-1-the-force-trial-pilot-fish-oil-enriched-nutrition-for-radiotherapy-in-cancer-of-the-head-and-neck-100606824",false,"NCT07180576","The FORCE Trial Pilot: Fish Oil-enriched Nutrition for Radiotherapy in Cancer of the hEad and Neck","The FORCE Trial Pilot","FORCE","Inclusion Criteria:\n\n* Newly diagnosed with Stage I - IV oral cavity, hypopharyngeal, oropharyngeal, or laryngeal cancer\n* Age 18+\n* Planned for definitive radiotherapy with or without surgery and chemotherapy\n\nExclusion Criteria:\n\n* Metastatic disease\n* Prior head\u002Fneck RT\n* Presence of malnutrition at diagnosis per ASPEN criteria\n* Prior cancer within 3 years (except non-melanoma skin cancer and cervical carcinoma in situ)\n* Inability to consent\n* Severe psychiatric illness\n* Medical conditions impairing participation\u002Fadherence\n* Non-adults, pregnant women, prisoners, and other legally protected vulnerable groups\n* Dairy, soy, and\u002For fish allergy\n* Non-English speaking\n* Documented history of atrial fibrillation or other significant arrhythmias\n* Receiving therapeutic anticoagulation (e.g., warfarin, direct oral anticoagulants) and\u002For clotting disorders (e.g., hemophilia, thrombocytopenia)","ALL","18 Years",{"count":20,"type":21},15,"ESTIMATED","INTERVENTIONAL",[24,25],"PHASE1","PHASE2","en-label, proof-of-concept study designed to evaluate the feasibility, safety, and acceptability of a prophylactic fish oil-enriched nutritional supplement (Fresubin Supportan) in patients with head and neck cancer (HNC) undergoing curative-intent chemoradiotherapy (CRT) at the University of Kansas Medical Center. The study involves daily supplementation starting two weeks prior to CRT and continuing throughout CRT, alongside weekly nutrition counseling.",[28],"Head &Amp;Amp; Neck Squamous Cell Carcinoma",[30,31,32,33,34,35,36,37,38,39,40,41,42,43,44],"nutrition","head and neck cancer","nutrition supplement","nutrition trial","fish oil","cancer patient","sarcopenia","nutrition impact symptoms","body composition","cancer","oncology","fatty acid","cancer survivor","oral nutrition supplement","supportive care","NOT_YET_RECRUITING","2025-09-11",{"date":48,"type":49},"2025-09-18","ACTUAL",{"date":51,"type":21},"2026-01-01",{"date":53,"type":21},"2027-12-31",{"name":55,"class":56},"Anna Arthur, PhD","OTHER",""]